Apple, Johnson & Johnson study to predict stroke risk with Apple Watch

[ad_1]

Jeff Williams, Chief Operating Officer of Apple, speaks about the the new Apple Watch Series 4 at an Apple Inc product launch event at the Steve Jobs Theater in Cupertino, California, September 12, 2018.

Stephen Lam | Reuters

The Heartline Study app

Johnson & Johnson

“The Heartline Study is a nationwide, randomized, controlled, app-based, virtual research study sponsored by Janssen Pharmaceuticals, Inc., a member of the Janssen Pharmaceutical Companies of Johnson & Johnson,” the companies said. “The team worked with Apple to jointly design the research study and the Heartline Study app.”

Open enrollment for the new study begins Tuesday. It’s open to Apple Watch owners who are 65 years of age or older, live in the U.S. and own an iPhone 6s or newer. Participants with traditional Medicare are eligible to participate. The app is available for free in the iTunes App Store.

The Heartline study app

Johnson & Johnson

Heartline will last three years and includes two years of active engagement and one year of additional data collection, Johnson & Johnson said.

Apple and Stanford published the results of an earlier heart study in November. That research included 419,000 participants over 8 months and found that just over 2,000 people received a notification of an irregular pulse. But results of that were debated and many agreed that they were still preliminary. 

[ad_2]

Source link